Besides TNF-α inhibition, the IMID itself, the recent or concomitant use of other immunosuppressive drugs (especially corticosteroids), and co-existing comorbidities often contribute to increasing the risk of TB in this particular patient population. Here, TNF is linked to tuberculosis.